Skip to main content
. Author manuscript; available in PMC: 2010 Mar 19.
Published in final edited form as: Mol Ther. 2008 Jan 22;16(3):458–465. doi: 10.1038/sj.mt.6300389

Table 2.

Percent enhanced green fluorescent protein (eGFP) expression by 84–31 cells in the presence of serum samples from AAVRPE65-treated Briard dogs

Serum dilution BR329
baseline
BR329
5 weeks
BR332
baseline
BR332
5 weeks
BR332
3 months
BR334
baseline
BR334
5 weeks
BR334
3 months
1:5 94 ± 10 6 ± 1   93 ± 5 5 ± 2 5 ± 2 107 ± 26 4 ± 2 3 ± 0
1:10 104 ± 6 6 ± 1 101 ± 4 6 ± 2 6 ± 2 113 ± 16 7 ± 5 5 ± 1
1:100 110 ± 13 6 ± 2   99 ± 10 7 ± 1 120 ± 6 106 ± 14 5 ± 2 113 ± 15
1:1,000 107 ± 4 118 ± 8 105 ± 5 18 ± 4 95 ± 8 102 ± 11 48 ± 8 98 ± 10
1:10,000 115 ± 12 98 ± 8 103 ± 8 95 ± 7 100 ± 5 103 ± 7 96 ± 3 99 ± 5

Numbers reflect the percent eGFP expression in presence of sample (mean ± SD). The percent eGFP expression in the absence of sample is 100 ± 6 (n = 36); results indicating ≥50% inhibition are shown in boldface text.